Show simple item record

dc.contributor.authorNoristani, Harun Najib
dc.contributor.authorSabourin, Jean Charles
dc.contributor.authorBoukhaddaoui, Hassan
dc.contributor.authorChan-Seng, Emilie
dc.contributor.authorGerber, Yannick Nicolas
dc.contributor.authorPerrin, Florence Evelyne
dc.date.accessioned2019-04-09T13:13:42Z
dc.date.available2019-04-09T13:13:42Z
dc.date.issued2016-10-06
dc.identifier.citationMolecular Neurodegeneration 11 : (2016) // Article ID 68es_ES
dc.identifier.issn1750-1326
dc.identifier.urihttp://hdl.handle.net/10810/32388
dc.description.abstractBackground: Neurons have intrinsic capability to regenerate after lesion, though not spontaneously. Spinal cord injury (SCI) causes permanent neurological impairments partly due to formation of a glial scar that is composed of astrocytes and microglia. Astrocytes play both beneficial and detrimental roles on axonal re-growth, however, their precise role after SCI is currently under debate. Methods: We analyzed molecular changes in astrocytes at multiple stages after two SCI severities using cell-specific transcriptomic analyses. Results: We demonstrate that astrocyte response after injury depends on both time after injury and lesion severity. We then establish that injury induces an autologous astroglial transdifferentiation where over 10 % of astrocytes express classical neuronal progenitor markers including beta III-tubulin and doublecortin with typical immature neuronal morphology. Lineage tracing confirmed that the origin of these astrocytes is resident mature, rather than newly formed astrocytes. Astrocyte-derived neuronal progenitors subsequently express GABAergic, but not glutamatergic-specific markers. Furthermore, we have identified the neural stem cell marker fibroblast growth factor receptor 4 (Fgfr4) as a potential autologous modulator of astrocytic transdifferentiation following SCI. Finally, we establish that astroglial transdifferentiation into neuronal progenitors starts as early as 72 h and continues to a lower degrees up to 6 weeks post-lesion. Conclusion: We thus demonstrate for the first time autologous injury-induced astroglial conversion towards neuronal lineage that may represent a therapeutic strategy to replace neuronales_ES
dc.description.sponsorshipThis work was supported by the Spanish Government, Plan Nacional de I + D + I 2008-2011 and ISCIII-Subdireccion General de Evaluacion y Fomento de la investigacion (PI10/00709) [to FEP] and the Government of the Basque Country grant (Proyectos de Investigacion Sanitaria and Fondo Comun de Cooperacion Aquitania-Euskadi) [to FEP], the French Government, ANR-FNS grant, GliALS (No ANR-14-CE36-0009-01) [to FEP], the patient organizations "Demain Debout Aquitaine" [to YNG and HNN] and "Verticale" [to FEP and HNN]. The authors declare no conflicts of interests.es_ES
dc.language.isoenges_ES
dc.publisherBiomed Centrales_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectspinal cord injuryes_ES
dc.subjectastrocyteses_ES
dc.subjectastrogliosises_ES
dc.subjecttransdifferentiationes_ES
dc.subjectcell specific transcriptomices_ES
dc.subjectin-vivoes_ES
dc.subjectreactive astrogliosises_ES
dc.subjectglial scares_ES
dc.subjectastrocyteses_ES
dc.subjectmicrogliaes_ES
dc.subjectbraines_ES
dc.subjecttranscriptomees_ES
dc.subjectcellses_ES
dc.subjectmousees_ES
dc.subjectmodeles_ES
dc.titleSpinal cord injury induces astroglial conversion towards neuronal lineagees_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holderThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise statedes_ES
dc.rights.holderAtribución 3.0 España*
dc.relation.publisherversionhttps://molecularneurodegeneration.biomedcentral.com/articles/10.1186/s13024-016-0133-0es_ES
dc.identifier.doi10.1186/s13024-016-0133-0
dc.departamentoesNeurocienciases_ES
dc.departamentoeuNeurozientziakes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated
Except where otherwise noted, this item's license is described as This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated